Amgen Inc (AMGN)
309.92
-2.90
(-0.93%)
USD |
NASDAQ |
May 10, 14:34
Amgen Price: 309.92 for May 10, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 09, 2024 | 309.53 | 314.60 | 306.32 | 312.82 | 2.281M |
| May 08, 2024 | 300.12 | 307.57 | 298.89 | 307.31 | 2.860M |
| May 07, 2024 | 301.75 | 302.91 | 298.51 | 300.30 | 2.452M |
| May 06, 2024 | 310.88 | 312.73 | 297.52 | 299.48 | 4.718M |
| May 03, 2024 | 313.39 | 322.60 | 308.68 | 311.29 | 9.645M |
| May 02, 2024 | 277.69 | 278.63 | 274.90 | 278.39 | 3.177M |
| May 01, 2024 | 274.18 | 279.84 | 273.38 | 277.37 | 2.324M |
| Apr 30, 2024 | 276.11 | 276.12 | 272.35 | 273.94 | 2.477M |
| Apr 29, 2024 | 269.18 | 276.86 | 268.99 | 276.38 | 2.679M |
| Apr 26, 2024 | 265.72 | 271.68 | 265.72 | 269.98 | 2.437M |
| Apr 25, 2024 | 273.45 | 274.35 | 267.24 | 269.38 | 1.794M |
| Apr 24, 2024 | 270.63 | 274.86 | 269.64 | 273.01 | 2.467M |
| Apr 23, 2024 | 272.14 | 274.48 | 271.05 | 273.54 | 2.493M |
| Apr 22, 2024 | 269.84 | 273.14 | 269.84 | 271.91 | 2.166M |
| Apr 19, 2024 | 264.63 | 269.38 | 260.68 | 268.93 | 3.380M |
| Apr 18, 2024 | 265.64 | 265.92 | 262.58 | 262.75 | 2.083M |
| Apr 17, 2024 | 267.54 | 268.78 | 263.38 | 264.07 | 2.175M |
| Apr 16, 2024 | 266.83 | 267.51 | 263.81 | 265.64 | 2.018M |
| Apr 15, 2024 | 269.93 | 270.93 | 264.34 | 265.51 | 1.740M |
| Apr 12, 2024 | 268.77 | 269.30 | 266.16 | 267.28 | 2.140M |
| Apr 11, 2024 | 270.22 | 273.00 | 268.44 | 270.00 | 2.170M |
| Apr 10, 2024 | 267.96 | 268.38 | 264.63 | 266.45 | 1.950M |
| Apr 09, 2024 | 270.19 | 271.29 | 268.58 | 270.36 | 1.793M |
| Apr 08, 2024 | 269.48 | 270.21 | 267.56 | 269.20 | 1.831M |
| Apr 05, 2024 | 265.90 | 273.07 | 265.08 | 269.95 | 2.294M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
166.70
Minimum
May 31 2019
324.56
Maximum
Feb 01 2024
237.99
Average
237.21
Median
May 12 2020
Price Benchmarks
| Gilead Sciences Inc | 65.84 |
| Johnson & Johnson | 149.40 |
| Eli Lilly and Co | 763.21 |
| Merck & Co Inc | 130.43 |
| Vertex Pharmaceuticals Inc | 422.14 |
Price Related Metrics
| PE Ratio | 44.27 |
| PS Ratio | 5.638 |
| Price to Book Value | 33.10 |
| Price to Free Cash Flow | 23.46 |
| Earnings Yield | 2.26% |
| Market Cap | 166.25B |
| Operating PE Ratio | 23.90 |
| Normalized PE Ratio | 44.27 |